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BBMT HAS ENHANCED
WEB SITE; NEW FUNCTIONS
Biology of Blood and Marrow Trans-
plantation has an improved Web site.
The URL remains the same at www.
bbmt.org, but the appearance and
functionality have been updated.
The new streamlined design is
based on leading-edge technologies,
providing easier access and usability.
New features include:
● Searches across 400 journals and
Medline
● Linking to full-text articles in other
journals via cited references
● E-mail alerts to help users stay in-
formed about new developments
A database of all current users has
been migrated to the new platform. If
you had a username and a password
on the old platform, you will be asked
to complete some registration details
the first time you log in, and you will
need to confirm your username and
password for continued access to the
full-text articles in the journal.
A few past users may not be able to
log in using their old username and
password if there were duplicate ac-
counts in the former database. These
users will receive an email describing
the database migration and directions
for continued access to the Web site.
If you have trouble accessing your
account, contact the journal’s custo-
mer service department to look up your
account details and provide assistance:
(800) 654-2452 or elspcs@elsevier.com.
ASBMT BOARD APPROVES
2006 JOURNAL EXPANSION
For the third consecutive year, Biol-
ogy of Blood and Marrow Trans-
plantation will grow by another 96
pages—an average eight pages per
issue—beginning Jan. 1.
Since 2004, the overall size of the
journal, measured in editorial pages,
has increased 38 percent. “The growth
is the result of an ever-increasing
number of quality manuscripts and
the economic health of the journal,”
said Daniel Weisdorf, MD, chair of the
ASBMT Publications Committee.
NEW INVESTIGATORS ELIGIBLE
FOR $5,000 EDITORIAL AWARDS
Each year ASBMT presents two ed-
itorial awards to new investigators
published in Biology of Blood and
Marrow Transplantation.
● George Santos Award for best
clinical research article
● Ernest McCulloch & James Till
Award for best basic science article
Both awards are accompanied by a
$5,000 prize that is presented at the
BMT TandemMeetings. The two awards
are supported by educational grants
from StemCell Technologies Inc. and
StemSoft Software Inc., Vancouver.
Recipients must be not more than five
years past a graduate or post-doctoral
program or a clinical research fellow-
ship, or currently active in a training
program as a clinical resident or fellow,
post-doctoral fellow, medical student,
graduate student, or undergraduate stu-
dent. The winning articles must be pub-
lished in the current (2005) volumeof the
journal (Vol. 11).
Many authors choose Biology of
Blood and Marrow Transplantation
for submitting basic and clinical re-
search articles because:
● The readership is highly focused in
the field of hematopoietic progen-
itor stem cell transplantation.
● The turnaround time from article ac-
ceptance to publication averages
40 days for a “rapid publication”
and 75 days for a regular article.
● There are no author page charges.
● The journal has an ISI Impact Fac-
tor of 3.278, ranking it among the
top transplant journals.
The judging committee for the edito-
rial awards is the BBMT Editorial Board
and ASBMT Publications Committee.
REGISTER ONLINE FOR BMT
TANDEM MEETINGS IN HAWAII
Online registration and housing
reservations are open for the 2006
BMT Tandem Meetings that will be
held Feb. 16–20 in Honolulu.
On a single Web page at www.
asbmt.org, registrants can navigate to
meeting registration, housing reserva-
tions, preliminary program, abstract sub-
mission, travel discounts, and local tours.
Information also is provided that
compares the cost of travel and lodg-
ing for Hawaii versus other conven-
tion locations.
ASBMT/ASTELLAS LAUNCH
NEW INVESTIGATOR AWARD
A $25,000-per-year award for new
investigators has been introduced by
ASBMT in cooperation with Astellas
Pharma US, Inc. The award will be
given at the 2006 BMT Tandem Meet-
ings in February in Honolulu.
The deadline for applications is
Dec. 1, 2005.
Funded by an educational grant
from Astellas Pharma US, the two-
year award encourages clinical and
laboratory research by new investiga-
tors in the field of blood and marrow
transplantation. Applicants must be at
the junior faculty level (instructor or
assistant professor) and be an ASBMT
member or sponsored by an ASBMT
member.
The award application is postedon the
ASBMT Web site at www.asbmt.org.
Astellas was formed in April this
year by the merger of Fujisawa
Pharmaceutical Co. and Yamanouchi
Pharmaceutical Co.
REVIEW APPROVED FOR ACUTE
LYMPHOBLASTIC LEUKEMIA
The ASBMT Steering Committee on
Evidence-Based Reviews and an ex-
pert panel chaired by Donna Wall,
MD, of Texas Transplant Institute, San
Antonio, have completed work on
two new reviews on adult and pedi-
atric acute lymphoblastic leukemia
(ALL). The reviews will be published
later this year in Biology of Blood and
Marrow Transplantation.
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